Publications by authors named "John Francis Callan"

Background: Vulvovaginal candidiasis (VVC) is a worldwide public health problem caused predominantly by the opportunistic polymorphic fungus , whose pathogenicity is associated with its morphological adaptability. To potentiate the treatment of -induced VVC by an alternative method as photodynamic therapy (PDT), hypericin (Hy), a potent photosensitizer compound was incorporated into a nanostructured lipid carrier (NLC) and dispersed in hydrogel (HG).

Methods: After preparation of the sonication process, an NLC loaded with Hy was dispersed in HG based on Poloxamer 407 and chitosan obtaining Hy.

View Article and Find Full Text PDF

Candida albicans biofilms exhibit unique characteristics and are highly resistant to antifungal agents. Antimicrobial photodynamic therapy (aPDT) is an alternative treatment limited to treating superficial infections due to the poor light penetration. In this manuscript, the antifungal properties of sonodynamic therapy (SDT) were assessed.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "John Francis Callan"

  • - John Francis Callan's recent research focuses on innovative treatment methods for fungal infections, particularly vulvovaginal candidiasis (VVC) caused by *Candida albicans*, utilizing advanced photodynamic and sonodynamic therapies to enhance antifungal efficacy.
  • - His 2023 study introduces hypericin-loaded nanostructured lipid carriers in hydrogels as an innovative photodynamic treatment for VVC, aiming to improve the effectiveness against the opportunistic fungus through targeted drug delivery.
  • - In earlier research from 2018, Callan explored the limitations of traditional antifungal therapies against *Candida albicans* biofilms, highlighting the potential of sonodynamic therapy as a viable alternative to overcome resistance and improve treatment outcomes.